AF
TXMD icon

Amalgamated Financial’s TherapeuticsMD TXMD Stock Holding History

Amalgamated Financial’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$24K Buy
+1,270
New +$20K ﹤0.01% 2687

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Amalgamated Financial's TXMD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in TherapeuticsMD (TXMD) in Q1 2022: 1,270 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #2687 among its holdings.

124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

  • Amalgamated Financial held 1,270 shares of TherapeuticsMD worth $24K as of Q1 2022.
  • TherapeuticsMD was a new Amalgamated Financial position in Q1 2022.
  • TherapeuticsMD made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2687 holding.
  • 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.